Pre-Proposals due December 15, 2015!
We are looking for big translational ideas for point of care technologies!
- Can you create a blood test that could replace the mammogram?
- Can you create a test to predict the onset of resistance to therapy?
- Do you have a bioreactor technology that could reduce the cost and complication of personalized treatments like T cell therapy?
- Have you designed a mobile app that could get significant numbers of at risk people to quit smoking?
The questions above are examples of the kinds of breakthrough technologies in point of care that could revolutionize the way that cancer is diagnosed and treated.The Center for Future Technologies in Cancer Care (CFTCC) seeks innovative proposals that focus on translational technologies that meet a need in contemporary cancer care. A clear articulation of the potential impact of a successful demonstration of the proposed technology must be given. Proposals that could impact significant numbers of people will be prioritized.
We plan to fund 2-3 projects for one year starting in July 2016. Budgets of up to $200,000 in direct costs may be requested. Proposals can focus on needs in the areas of screening, diagnosis or treatment. Diagnosis includes staging of both new and recurrent disease. Treatment can include improved treatment mechanisms (e.g. drug delivery methods), treatment monitoring methods, and/or quality of life interventions for patients in treatment.
Submission is open to anyone eligible to apply for an NIH R grant. There is no requirement for applicants to be affiliated with Boston University or to collaborate with affiliates of Boston University.
We anticipate funding approximately 2-3, 12 month grants each totaling $200,000 total direct cost. Indirect costs will be covered at your institution’s NIH negotiated rate.